stockrow
Friday 6 November 2026
Export RCUS’s income statement to Excel — free account
Arcus Biosciences, Inc.
RCUS Healthcare Biotechnology
Arcus Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $247.0 million, down 4.26% from fiscal 2024.
- Revenue
- −65.4%
- EPS
- +21.3%
- Free cash flow
- +9.28%
- Total debt
- +4.08%
Quarter to September 2026, against a year earlier
18.36
0.67
+3.79%
Follow RCUS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
0 | 1 | 0 | 0 |
| (63.26%) | (69.95%) | (90.82%) | (114.11%) | ||
| (30.84%) | (34.28%) | (46.02%) | (50.56%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(43.26%) | (54.83%) | (77.44%) | (90.96%) | |
Average Days of Receivables |
16.26 | 4.64 | 112.31 | 65.70 | |
Free Cash Flow per Share |
(4.51) | (3.89) | (3.76) | (3.65) | |
Free Cash Flow |
(484.00) | (488.00) | (474.00) | (465.00) | |
Capital Expenditures |
(2.00) | — | — | — | |
| Other line items | |||||
Cash ROIC |
(28.29%) | (33.75%) | (37.41%) | (42.66%) | |
Accounts Receivable Turnover |
15.94 | 26.22 | 4.59 | 6.90 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
211.74% | 221.61% | 424.79% | 473.00% | |
Selling, General and Administrative Expense of Revenue |
44.53% | 47.03% | 90.60% | 102.00% | |
Share Based Compensation of Revenue |
24.29% | 26.69% | 53.85% | 65.00% | |
Interest Coverage |
(48.25) | (39.80) | (44.18) | (43.18) | |
Operating CF/Net income |
1.37 | 1.32 | 1.03 | 1.03 | |
Depreciation/Fixed assets |
(0.07) | (0.08) | 0.00 | 0.00 | |
Capex/Depreciation |
0.67 | 0.00 | — | — | |
Revenue per Share |
2.30 | 1.88 | 0.93 | 0.78 | |
Operating CF per Share |
(4.49) | (3.89) | (3.76) | (3.65) | |
Capex per Share |
(0.02) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 4 Nov 2026